Pan-cancer characterization of ncRNA synergistic competition uncovers potential carcinogenic biomarkers
Fig 6
Molecular subtype analysis of malignant tumors.
(a) Molecular subtyping of the 31 malignant tumors using ncRNA synergistic competition networks and hub ncRNAs. Higher average silhouette width indicates that a malignant tumor sample is better matched with the identified molecular subtypes. (b) Molecular subtyping of LGG using ncRNA synergistic competition network. (c) Molecular subtyping of LGG using hub ncRNAs. (d) Classification analysis of BRCA subtypes.